[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100543923":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":28,"locations":34,"responsibleParty":54,"collaborators":11,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":11,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":11,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":11,"overallStatus":76,"whyStopped":11,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Cedars-Sinai Medical Center","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Gut Directed VR","EXPERIMENTAL",null,[13],"Device: Gut Directed VR",{"label":15,"type":16,"description":11,"interventionNames":17},"Sham VR","SHAM_COMPARATOR",[18],"Device: Sham Control VR",[20,24],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":11},"DEVICE","The VR experiences follow a protocolized gut-directed therapy",[9],{"type":21,"name":25,"description":26,"armGroupLabels":27,"otherNames":11},"Sham Control VR","The same Oculus Quest 2 device as the active treatment group but will use distractive therapy",[15],[29],{"name":30,"role":31,"phone":32,"phoneExt":11,"email":33},"Arax Shanlian","CONTACT","(310) 967-1110","Arax.Shanlian@cshs.org",[35],{"facility":5,"status":11,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Los Angeles","California","90048","United States","US",{"type":42,"coordinates":43},"Point",[44,45],-118.24368,34.05223,{"lat":45,"lon":44},[48,51],{"name":30,"role":31,"phone":49,"phoneExt":11,"email":50},"3109671110","arax.shanlian@cshs.org",{"name":52,"role":53,"phone":11,"phoneExt":11,"email":11},"Stephen Pandol, MD","PRINCIPAL_INVESTIGATOR",{"type":53,"investigatorFullName":52,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"Director, Basic and Translational Pancreas Research Medicine","100543923","vr-pilot-for-pancreatitis-100543923",false,"NCT06362187","VR Pilot for Pancreatitis","A Feasibility Study on Gut-Directed Virtual Reality for Chronic Pain Related to Chronic Pancreatitis","Inclusion Criteria:\n\n* Diagnosis of CP \\[as determined by Cambridge 3-4 imaging classification (using CT, MRI, or MRCP) or a histologic diagnosis of CP\\]\n* Clinically significant abdominal pain, measured using the standardized NIH PROMIS GI Pain Scale14 and defined as scoring at least 5 points above the nationally normed score (0.5 SD effect size), indicating equal or greater than the minimally clinically important difference (MCID) of abdominal pain\n* Are 18-75 years of age\n* Are able to read\u002Fwrite English. The study does not include non-English speakers as to current study material are only available in English.\n\nExclusion Criteria:\n\n* Patients who are presenting with a condition that interferes with VR usage (e.g., seizures, facial injury precluding safe placement of headset, visual impairment)\n* Patients who have cognitive impairment that affects protocol participation\n* Patients who are recommended for long-term hospitalization\n* Patients who are estimated to live \\\u003C3 months from the time of enrollment\n* Patients who have been diagnosed with a pancreatic tumor\n* Patients who have been enrolled in an interventional\u002Ftherapeutic drug trial for chronic or recurrent pancreatitis within the last 6 months","ALL","18 Years","75 Years",{"count":67,"type":68},20,"ESTIMATED","INTERVENTIONAL",[71],"NA","The purpose of the research is to test the feasibility and preliminary impact of a home-based, standardized, gut-directed, virtual reality cognitive behavioral therapy (VR CBT) on clinical and functional outcomes of patients with chronic pancreatitis (CP) pain. The primary research procedures are questionnaires and biometric Fitbit data. The study will enroll adult patients with CP.",[74,75],"Chronic Pancreatitis","Recurrent Pancreatitis","NOT_YET_RECRUITING","2026-02-21",{"date":79,"type":80},"2026-02-24","ACTUAL",{"date":82,"type":68},"2026-07-22",{"date":84,"type":68},"2028-05",{"name":5,"class":6},1]